Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CAMBIUM BIO LIMITED Capital/Financing Update 2014

Aug 5, 2014

64666_rns_2014-08-05_207b2c32-8eb6-40aa-b6d2-060c8fa77012.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [104 x 96] intentionally omitted <==

MARKET RELEASE

6 August 2014

Regeneus Ltd

TRADING HALT

The securities of Regeneus Ltd (the “Company”) will be placed in Trading Halt Session State at the request of the Company, pending the release of an announcement by the Company. Unless ASX decides otherwise, the securities will remain in Trading Halt Session State until the earlier of the commencement of normal trading on Friday, 8 August 2014 or when the announcement is released to the market.

Security Code: RGS

Stephanie Yong Senior Adviser, Listings Compliance (Sydney)

==> picture [159 x 33] intentionally omitted <==

6 August 2014

ASX Limited Exchange Centre 20 Bridge Street

SYDNEY NSW 2000

Attention: Stephanie Yong

Dear Stephanie

Request for Trading Halt – Regeneus Ltd (Regeneus)

In accordance with Listing Rule 17.1, Regeneus requests an immediate trading halt in its ordinary securities listed on the ASX.

Regeneus advises the following, as required under Listing Rule 17.1:

  1. the trading halt is necessary as Regeneus proposes to make an announcement to the market in relation to a potential capital raising;

  2. a series of presentations will be made to potential investors in the capital raising – once finalised the results of the capital raising, together with the information presented to investors will be announced to the ASX;

  3. Regeneus wishes the trading halt to last until the announcements are released – expected to be prior to the commencement of normal trading on Friday, 8 August 2014; and

  4. Regeneus is not aware of any reason why the trading halt should not be granted by the ASX and is not aware of any other information that is necessary to inform the market about the trading halt.

Please contact me if you have any queries.

Yours sincerely

==> picture [217 x 127] intentionally omitted <==

John Martin Executive Chairman Regeneus Ltd

25 Bridge Street, Pymble, NSW 2073 • PO Box 20, Gordon, NSW 2072 Ph: +61 2 9499 8010 • Fax: +61 2 9499 8020 • www.regeneus.com.au • ABN 13 127 035 358

26126548 v1 National 06 08 14